Durham biotech Brii to receive $24M for its stake in sale of US drug firm

Durham-based Brii Biosciences will net some $24 million up front and also secured future royalty payments in a deal involving the sale of its share in a biotech that's being acquired by Japan-based pharmaceutical company Shionogi.

Related Keywords

China ,San Diego ,California ,United States ,Japan ,Qpex Biopharma ,Zhi Hong ,Brii Bio ,Brii Biosciences ,Brii Biosciences Limited Bio ,National Medical Products Administration ,Biosciences Announces Entry ,Definitive Agreements ,Equity Interest ,Acquiring Exclusive Global Rights ,Brii Biosciences Limited ,Greater China ,Chief Executive Officer ,